Bausch Health Companies (BHC) EBT Margin (2009 - 2026)
Bausch Health Companies (BHC) reported EBT Margin of 53.65% for Q1 2026, down 5156.0% on a YoY basis from 1.06% in Q1 2025, and down 2778.42% sequentially from 2.0% in Q4 2025.
Bausch Health Companies (BHC) EBT Margin (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of EBT Margin data on file, last reported at 53.65% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 5156.0% year-over-year to 53.65%; the trailing twelve-month figure through Mar 2026 stood at 8.93% (down 1087.0% YoY), and the FY2025 full-year result was 3.57%, up 184.0% from the prior year.
- EBT Margin fell to 53.65% in Q1 2026, from 2.0% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 21.46% in Q3 2022 to a low of 53.65% in Q1 2026.
- A 5-year average of 3.4% and a median of 0.84% in 2024 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin soared 2535 bps in 2022 and plunged 5156 bps in 2026, its largest moves.
- Tracing BHC's EBT Margin over 5 years: stood at 16.28% in 2022, then soared by 98 bps to 0.29% in 2023, then jumped by 2910 bps to 8.17% in 2024, then slumped by 75 bps to 2.0% in 2025, then tumbled by 2778 bps to 53.65% in 2026.
- Business Quant data shows BHC's EBT Margin at 53.65% in Q1 2026, 2.0% in Q4 2025, and 8.13% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | -53.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.65% |
| Dec 31, 2025 | 2.00% |
| Sep 30, 2025 | 8.13% |
| Jun 30, 2025 | 5.53% |
| Mar 31, 2025 | -2.08% |
| Dec 31, 2024 | 8.17% |
| Sep 30, 2024 | -0.84% |
| Jun 30, 2024 | 2.00% |
| Mar 31, 2024 | -3.20% |
| Dec 31, 2023 | -0.29% |
| Sep 30, 2023 | -14.57% |
| Jun 30, 2023 | 3.65% |
| Mar 31, 2023 | -7.00% |
| Dec 31, 2022 | -16.28% |
| Sep 30, 2022 | 21.46% |
| Jun 30, 2022 | -6.56% |
| Mar 31, 2022 | -4.28% |
| Dec 31, 2021 | 0.29% |
| Sep 30, 2021 | 10.23% |
| Jun 30, 2021 | -31.90% |